Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

“Good Directors” Recruiting, Training & Placement (The Directors Letter)

Related Content

Thinking Outside the Buyout: Four Factors Management Teams Need to Get Right

Six Considerations for Directors Navigating Distressed M&A

FDIC Board of Directors Withdraws Three Outstanding Proposed Rules

How to Navigate Deal Delays and Completion Uncertainty in an Era of Heighted Deal Complexity and Prolonged Interim Period

Non-financial Misconduct and Culture: A Reminder for FCA-Regulated Firms in the UK

Stalking Horse Bidders: What Bid Protections Can You Expect in a Section 363 Sale?

Tech M&A Poised for Growth in 2025 Despite Temporary Challenges

Acting FDIC Chairman Expresses Support for Enhancing Flexibility of Customer Identification Program Requirements

Goodwin Leads M&A, Private Equity, and Venture Capital League Table Rankings for 2024

Goodwin Advised Guaranty Bancorp in $41.6 Million Merger with Bar Harbor

2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share

Goodwin First-Year Lawyers Embed with Clients in Unique Program (Bloomberg Law)

Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business For €760 Million

Goodwin Advised Voyage AI on Sale to MongoDB

Chambers Global 2025 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

Anthos Therapeutics To Be Acquired by Novartis For Up To $3.1 Billion

Mergers & Acquisitions